Back

Metabolomic reprogramming of subcutaneous adipose tissue aggravates atherosclerosis via impaired adipocyte-macrophage crosstalk

30 August 2024 (15:20 - 15:30)
Organised by: Logo
Congress Presentation Part of: Lipids and adipose tissue interaction in cardiovascular disease Lipids, Metabolism ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Doctor Bowen Lou

the First Affiliated Hospital of Xi'an Jiaotong University, Xi'an (China)

5 More presentations in this session

Presentation thumbnail
Lipoprotein(a) induces spontaneous aortic dissection via increasing monocyte mediated vascular smooth muscle cell phenotype transformation in human Lp(a) transgenic mice
Doctor C. Han (Shanghai, CN)
Abstract Slides Video
Presentation thumbnail
Lipoprotein(a) regulates vascular redox state and inflammatory response in patients with coronary artery disease
Doctor I. Badi (Oxford, GB)
Abstract Slides Video
Presentation thumbnail
Targeting an altered sphingolipid profile with consecutive lipotoxicity as therapeutic approach to calcific aortic valve disease
Mr T. Rusack (Luebeck, DE)
Abstract Slides Video
Presentation thumbnail
Stress memory of heart failure in hematopoietic niche promotes recurrence via adipocytic skewing of mesenchymal stromal cells
Doctor K. Goto (Tokyo, JP)
Abstract Slides Video
Presentation thumbnail
Human epicardial adipose tissue secretome alters metabolomic profile and induces endothelial-to-mesenchymal transition in human lymphatic endothelial cells
Doctor I. Abe (Oita, JP)
Abstract Slides Video

Access the full session

Session thumbnail
Lipids and adipose tissue interaction in cardiovascular disease
Video

The Event

Event poster

ESC Congress 2024

30 August 2024 15:20 CET
You may be interested in
thumbnail
Congress Session
Lipids and adipose tissue interaction in cardiovascular disease
thumbnail
Congress Session
Metabolic reprogramming and crosstalk in cardiometabolic and vascular disease
thumbnail
Congress Session
Vascular immunometabolism: emerging mechanisms and therapeutic opportunities

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources